New Trade for February 19th, 2025
CRISPR Therapeutics (CRSP): An Industry Pioneer with High Growth Potential
CRISPR Therapeutics (CRSP) is a mid-stage biotech company specializing in gene editing, and despite its...
Three Value Stocks That Could Outperform in 2025
With markets at a potential turning point, value stocks are looking increasingly attractive. Historically, stocks with lower forward price-to-earnings (P/E) ratios have outperformed their...
Three Strong Conviction Buys for the Week Ahead
In the ever-shifting landscape of the stock market, separating the wheat from the chaff is no easy feat. It's a world where the wrong...
Bear Watch Weekly: Stocks to Sideline Now
The right stocks can make you rich and change your life.
The wrong stocks, though… They can do a whole lot more than just "underperform."...
Four Investment Gems Warren Buffett Is Betting Big On
When Warren Buffett adds to Berkshire Hathaway's portfolio, it’s always worth a closer look. Buffett’s legendary investing success stems from identifying high-quality businesses with...
